Andrew Sussman
CIK 1515706 · View on SEC EDGAR ↗
First SEC filing: April 21, 2011 · Latest: April 21, 2011
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 13, 2017 | CVS | S 10b5-1 | 7,449 | $80.40 | $598,900 | 8,697 Direct | -46.14% | Disposed | 16.4% (price as of 2026-08-21) |
| March 13, 2017 | CVS | S 10b5-1 | 6,655 | $80.40 | $535,062 | 16,146 Direct | -29.19% | Disposed | 16.4% (price as of 2026-08-21) |
| April 1, 2016 | CVS | S 10b5-1 | 2,844 | $105.00 | $298,620 | 11,041 Direct | -20.48% | Disposed | -10.9% (price as of 2026-08-21) |
| April 10, 2015 | CVS | S 10b5-1 | 5,082 | $102.39 | $520,346 | 8,861 Direct | -36.45% | Disposed | -8.6% (price as of 2026-08-21) |
| April 10, 2015 | CVS | S 10b5-1 | 6,655 | $102.38 | $681,339 | 13,943 Direct | -32.31% | Disposed | -8.6% (price as of 2026-08-21) |
| April 10, 2015 | CVS | S 10b5-1 | 5,901 | $102.38 | $604,144 | 13,943 Direct | -29.74% | Disposed | -8.6% (price as of 2026-08-21) |
| Jan. 2, 2015 | CVS | S 10b5-1 | 4,220 | $95.67 | $403,727 | 2,817 Direct | -59.97% | Disposed | -2.2% (price as of 2026-08-21) |
| Sept. 2, 2014 | CVS | S 10b5-1 | 9,020 | $79.45 | $716,639 | 7,037 Direct | -56.17% | Disposed | 17.8% (price as of 2026-08-21) |
| April 2, 2014 | CVS | S 10b5-1 | 5,901 | $74.02 | $436,792 | 6,829 Direct | -46.36% | Disposed | 26.4% (price as of 2026-08-21) |
| April 2, 2014 | CVS | S 10b5-1 | 13,309 | $74.02 | $985,132 | 6,829 Direct | -66.09% | Disposed | 26.4% (price as of 2026-08-21) |
| Sept. 4, 2013 | CVS | S 10b5-1 | 9,020 | $58.36 | $526,407 | 3,963 Direct | -69.48% | Disposed | 60.4% (price as of 2026-08-21) |
| Oct. 4, 2012 | CVS | S 10b5-1 | 9,020 | $49.00 | $441,980 | 3,929 Direct | -69.66% | Disposed | 91.0% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| April 3, 2017 | CVS | Stock Option | Common Stock (37,567) | $78.05 | April 3, 2024 | 37,567 | Acquired |
| March 13, 2017 | CVS | Stock Option | Common Stock (6,655) | $45.07 | April 2, 2019 | 6,655 | Disposed |
| April 1, 2016 | CVS | Stock Option | Common Stock (23,301) | $104.82 | April 1, 2023 | 23,301 | Acquired |
| April 10, 2015 | CVS | Stock Option | Common Stock (6,655) | $45.07 | April 2, 2019 | 6,655 | Disposed |
| April 10, 2015 | CVS | Stock Option | Common Stock (5,901) | $54.53 | April 1, 2020 | 5,901 | Disposed |
| April 1, 2015 | CVS | Stock Option | Common Stock (23,968) | $102.26 | April 1, 2022 | 23,968 | Acquired |
| Sept. 2, 2014 | CVS | Stock Option | Common Stock (9,020) | $36.96 | Sept. 1, 2019 | 9,020 | Disposed |
| April 2, 2014 | CVS | Stock Option | Common Stock (5,901) | $54.53 | April 1, 2020 | 5,901 | Disposed |
| April 2, 2014 | CVS | Stock Option | Common Stock (13,309) | $45.07 | April 2, 2019 | 13,309 | Disposed |
| April 1, 2014 | CVS | Stock Option | Common Stock (29,373) | $74.29 | April 1, 2021 | 29,373 | Acquired |
| Sept. 4, 2013 | CVS | Stock Option | Common Stock (9,020) | $36.96 | Sept. 1, 2019 | 9,020 | Disposed |
| April 1, 2013 | CVS | Stock Option | Common Stock (23,604) | $54.53 | April 1, 2020 | 23,604 | Acquired |
| Oct. 4, 2012 | CVS | Stock Option | Common Stock (9,020) | $36.96 | Sept. 1, 2019 | 9,020 | Disposed |
| April 2, 2012 | CVS | Stock Option | Common Stock (26,619) | $45.07 | April 2, 2019 | 26,619 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 5 holdings
Securities held when first becoming an insider, per SEC Form 3.